EPIDEMIOLOGY AND IMMUNOGENETIC BACKGROUND OF ISLET CELL ANTIBODY POSITIVE NONDIABETIC SCHOOLCHILDREN - ULM-FRANKFURT POPULATION STUDY

被引:48
作者
BOEHM, BO
MANFRAS, B
SEISSLER, J
SCHOFFLING, K
GLUCK, M
HOLZBERGER, G
SEIDL, S
KUHNL, P
TRUCCO, M
SCHERBAUM, WA
机构
[1] UNIV HOSP FRANKFURT,SCH MED,DEPT GEN MED,ENDOCRINOL SECT,FRANKFURT,GERMANY
[2] UNIV HOSP ULM,SCH MED,DEPT GEN MED,ULM,GERMANY
[3] INST IMMUNOHEMATOL,FRANKFURT,GERMANY
[4] UNIV HOSP HAMBURG,SCH MED,DEPT IMMUNOHEMATOL,HAMBURG,GERMANY
[5] UNIV PITTSBURGH,CHILDRENS HOSP,SCH MED,DEPT PEDIAT,PITTSBURGH,PA 15260
关键词
D O I
10.2337/diabetes.40.11.1435
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Islet cell antibodies (ICAs) were determined in a large cohort of white nondiabetic schoolchildren (n = 4287) from a homogenous population in southern Germany. The prevalence of ICA levels greater-than-or-equal-to 5 Juvenile Diabetes Foundation (JDF) U was 1.05% (95% confidence interval 0.8-1.4%). Analysis of HLA-DR-beta and -DQ-beta alleles revealed that the specificities found to be increased in insulin-dependent (type I) diabetic subjects with the same ethnic background were also associated with ICA positivity in the nondiabetic schoolchildren. HLA-DR3 (P < 0.01) and -DR4 (P < 0.01) phenotypes and absence of Asp residue (P < 0.01) at codon 57 of the HLA-DQ beta-chain were significantly increased in ICA+ compared with control subjects. High levels of ICAs, which were categorized as either greater-than-or-equal-to 17 or greater-than-or-equal-to 30 JDF U, were found to be associated with amino acids other than Asp at position 57 of the HLA-DQ beta-chain. No association of ICA level was found for HLA-DR phenotypes.
引用
收藏
页码:1435 / 1439
页数:5
相关论文
共 23 条
[1]   ANALYSIS OF HLA-DQ GENOTYPES AND SUSCEPTIBILITY IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
BAISCH, JM ;
WEEKS, T ;
GILES, R ;
HOOVER, M ;
STASTNY, P ;
CAPRA, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (26) :1836-1841
[2]   PREVALENCE OF ISLET CELL ANTIBODIES, INSULIN-ANTIBODIES AND HYPERGLYCEMIA IN 2291 SCHOOLCHILDREN [J].
BERGUA, M ;
SOLE, J ;
MARION, G ;
PEREZ, MC ;
RECASENS, A ;
FERNANDEZ, J ;
CASAMITJANA, R ;
GOMIS, R .
DIABETOLOGIA, 1987, 30 (09) :724-726
[3]  
BETTERLE C, 1984, DIABETOLOGIA, V26, P431
[4]   SERUM EXCHANGE AND USE OF DILUTIONS HAVE IMPROVED PRECISION OF MEASUREMENT OF ISLET CELL ANTIBODIES [J].
BONIFACIO, E ;
LERNMARK, A ;
DAWKINS, RL ;
ARNAIZVILLENA, A ;
BARBOSA, J ;
BETTERLE, C ;
BOEHM, B ;
BOITARD, C ;
BOTTAZZO, GF ;
BRIGHT, GM ;
CHAPEL, H ;
DIMARIO, U ;
EISENBARTH, GS ;
ELLIOT, RB ;
GERBITZ, K ;
GLEICHMAN, H ;
HARRISON, L ;
HELMKE, K ;
HULINSKY, I ;
KOBAYASHI, T ;
KUMAR, WJ ;
LANDIN, M ;
MOLENAAR, JL ;
PALMER, JB ;
PETER, JB ;
REINAUER, KM ;
SCOTT, RS ;
SCOTTMORGAN, L ;
SCHERBAUM, WA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 106 (01) :83-88
[5]  
BRUINING GJ, 1989, LANCET, V1, P1100
[6]   ISLET-CELL ANTIBODIES AS PREDICTORS OF THE LATER DEVELOPMENT OF TYPE-1 (INSULIN-DEPENDENT) DIABETES - A STUDY IN IDENTICAL-TWINS [J].
JOHNSTON, C ;
MILLWARD, BA ;
HOSKINS, P ;
LESLIE, RDG ;
BOTTAZZO, GF ;
PYKE, DA .
DIABETOLOGIA, 1989, 32 (06) :382-386
[7]  
KARJALAINEN J, 1990, DIABETES, V39, pM44
[8]   EPIDEMIOLOGY OF ISLET CELL ANTIBODIES [J].
LIPTON, R ;
LAPORTE, RE .
EPIDEMIOLOGIC REVIEWS, 1989, 11 :182-203
[9]  
MACLAREN N, 1989, IMMUNOTHERAPY TYPE I, P147
[10]  
Maclaren NK, 1985, DIABETES S1, V34, p84A